CNBX Pharmaceuticals Inc. (CNBX) Research & Development (2014 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Research & Development came in at -$73934.0 in Q3 2024, down 179.3% YoY from $93235.0 in Q3 2023, and down 272.4% on a QoQ basis from $42884.0 in Q2 2024.
CNBX Pharmaceuticals Inc. (CNBX) Research & Development (2014 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 11 years of Research & Development data on file, last reported at -$73934.0 in Q3 2024.
- Quarterly Research & Development fell 179.3% year-over-year to -$73934.0 in Q3 2024, while the trailing twelve-month figure through May 2025 was -$73934.0 (down 120.78% YoY) and the FY2024 annual result came in at $194788.0, down 54.86% from the prior year.
- Research & Development declined to -$73934.0 in Q3 2024, from $42884.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $550842.0 in Q2 2021 to a low of -$1.2 million in Q3 2020.
- A 5-year average of $144354.3 and a median of $163599.0 in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2020 — Research & Development sank 355.46% — and 2021, when it soared 5727.63%.
- Tracing CNBX's Research & Development over 5 years: stood at $7551.0 in 2020, then soared by 5727.63% to $440044.0 in 2021, then slumped by 85.71% to $62888.0 in 2022, then jumped by 78.76% to $112418.0 in 2023, then tumbled by 165.77% to -$73934.0 in 2024.
- The last three Research & Development figures came in at -$73934.0 (Q3 2024), $42884.0 (Q2 2024), and $107199.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2024 | -73,934.00 |
| May 31, 2024 | 42,884.00 |
| Feb 29, 2024 | 107,199.00 |
| Nov 30, 2023 | 112,418.00 |
| Aug 31, 2023 | 93,235.00 |
| May 31, 2023 | 263,115.00 |
| Feb 28, 2023 | 12,328.00 |
| Nov 30, 2022 | 62,888.00 |
| Aug 31, 2022 | 163,599.00 |
| May 31, 2022 | 249,061.00 |
| Feb 28, 2022 | 330,576.00 |
| Nov 30, 2021 | 440,044.00 |
| Aug 31, 2021 | 471,003.00 |
| May 31, 2021 | 550,842.00 |
| Feb 28, 2021 | 315,958.00 |
| Nov 30, 2020 | 7,551.00 |
| Aug 31, 2020 | -1.22 Mn |
| May 31, 2020 | 370,084.00 |
| Feb 29, 2020 | 444,416.00 |
| Nov 30, 2019 | 466,033.00 |